• 1227 Citations
  • 16 h-Index
20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Silvia Mangiacavalli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Waldenstrom Macroglobulinemia Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hematopoietic Stem Cell Mobilization Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1227 Citations
  • 16 h-Index
  • 61 Article
  • 1 Letter
1 Citation (Scopus)
Monoclonal Gammopathy of Undetermined Significance
Waldenstrom Macroglobulinemia
Lymphoproliferative Disorders
Immunoglobulin M
Blood Proteins

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Marrow
Light
Plasma Cells
Serum

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

The advantages of switch to subcutaneous bortezomib in the real life

Mangiacavalli, S., Cocito, F., Ferretti, V. V., Ganzetti, M., Cartia, C. S. & Corso, A., Jun 2018, In : Leukemia and Lymphoma. 59, 6, p. 1505-1507 3 p.

Research output: Contribution to journalArticle